Translational Grant 2020 – EOI
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with your unit
Memorial Deadline: No RGCS review required for the EOI
External Deadline: Tuesday 14th, April 2020
Description
The Translational Grant aims to support and accelerate the translation of research discoveries into potential new treatments to protect and regenerate hearing and /or silence tinnitus. It funds projects at both academic institutions and small/medium enterprises in any country.
Action on Hearing Loss and Fondation Pour l’Audition are partnering to co-fund translational grants.
Why supporting the development of treatments for hearing loss and tinnitus is important?
There are almost half a billion people in the world with disabling hearing loss and 1.1 billion young people (aged between 12-35 years old) are at risk of losing their hearing due to recreational noise (WHO, 2018). The evidence of the link between hearing loss and debilitating conditions like dementia is strengthening (Livingston, G et al (2017) The Lancet). In the UK, one in ten people has tinnitus. However, there are currently no registered treatments that protect and/or restore hearing or silence tinnitus.
We request translational research proposals that will advance the development of small molecule, gene or cell-based therapeutics for the treatment of hearing disorders, including tinnitus.
We seek to support:
• research with a strong commercial potential that is likely to attract follow-on funding at the conclusion of the grant.
• studies that will facilitate and enable the progression of promising basic research towards testing in clinical trials.
Additional information can be found here.